← Eichor
Study identifier: NCT06311435 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19

Condition: Long COVID  ·  Sponsor: MaxWell Clinic, PLC

PhaseNA
Planned participants224
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The Primary objective of this study is to determine, using unblinded samples, if it is possible to develop an algorithm for the classification of specific blood RNA from patients with long COVID together and separately from the apparent health normal controls and other medical conditions that share the signs and symptoms of long COVID.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (3)

University of IowaIowa City, Iowa, United StatesNot Yet Recruiting
The MaxWell ClinicBrentwood, Tennessee, United StatesRecruiting
The MaxWell ClinicBrentwood, Tennessee, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06311435